Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged Current Cash

The latest current cash for NVOH is $15M as of September 2016. That compares with $18M in the prior-year period — down 15.8% year over year. Investors often review this figure alongside Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged's historical trend and sector peers before judging valuation or financial health.

Over the past year, NVOH's current cash moved from $18M to $15M — a 15.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged's operating scale or balance-sheet position.

A current cash figure of $15M for NVOH is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NVOH's current cash ($15M), review year-over-year change from $18M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.